Efficacy of enfuvirtide in patients infected with drugresistant HIV-1 in Europe and Australia

A Lazzarin; B Clotet; D Cooper; J Reynes; K Arasteh; M Neslon; C Katlama; HJ Stellbrink; JF Delfraissy; J Lange; L Huson; R DeMasi; C Wat; J Delehanty; C Drobnes; M Saldo; Marchina Ende; - TORO-2 study group

Efficacy of enfuvirtide in patients infected with drugresistant HIV-1 in Europe and Australia

A Lazzarin, B Clotet, D Cooper, J Reynes, K Arasteh, M Neslon, C Katlama, HJ Stellbrink, JF Delfraissy, J Lange, L Huson, R DeMasi, C Wat, J Delehanty, C Drobnes, M Saldo, Marchina Ende, - TORO-2 study group

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

625 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2186-2195
Number of pages	10
Journal	New England Journal of Medicine
Volume	348
Issue number	22
Publication status	Published - 2003

Research programs

EMC MM-04-28-04

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Lazzarin, A., Clotet, B., Cooper, D., Reynes, J., Arasteh, K., Neslon, M., Katlama, C., Stellbrink, HJ., Delfraissy, JF., Lange, J., Huson, L., DeMasi, R., Wat, C., Delehanty, J., Drobnes, C., Saldo, M., Ende, M., & TORO-2 study group, . (2003). Efficacy of enfuvirtide in patients infected with drugresistant HIV-1 in Europe and Australia. New England Journal of Medicine, 348(22), 2186-2195.

@article{1f1c2b614145437cad0aba7ce28f6be0,

title = "Efficacy of enfuvirtide in patients infected with drugresistant HIV-1 in Europe and Australia",

author = "A Lazzarin and B Clotet and D Cooper and J Reynes and K Arasteh and M Neslon and C Katlama and HJ Stellbrink and JF Delfraissy and J Lange and L Huson and R DeMasi and C Wat and J Delehanty and C Drobnes and M Saldo and Marchina Ende and {TORO-2 study group}, -",

year = "2003",

language = "Undefined/Unknown",

volume = "348",

pages = "2186--2195",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

Lazzarin, A, Clotet, B, Cooper, D, Reynes, J, Arasteh, K, Neslon, M, Katlama, C, Stellbrink, HJ, Delfraissy, JF, Lange, J, Huson, L, DeMasi, R, Wat, C, Delehanty, J, Drobnes, C, Saldo, M, Ende, M & TORO-2 study group 2003, 'Efficacy of enfuvirtide in patients infected with drugresistant HIV-1 in Europe and Australia', New England Journal of Medicine, vol. 348, no. 22, pp. 2186-2195.

TY - JOUR

T1 - Efficacy of enfuvirtide in patients infected with drugresistant HIV-1 in Europe and Australia

AU - Lazzarin, A

AU - Clotet, B

AU - Cooper, D

AU - Reynes, J

AU - Arasteh, K

AU - Neslon, M

AU - Katlama, C

AU - Stellbrink, HJ

AU - Delfraissy, JF

AU - Lange, J

AU - Huson, L

AU - DeMasi, R

AU - Wat, C

AU - Delehanty, J

AU - Drobnes, C

AU - Saldo, M

AU - Ende, Marchina

AU - TORO-2 study group, -

PY - 2003

Y1 - 2003

M3 - Article

SN - 0028-4793

VL - 348

SP - 2186

EP - 2195

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 22

ER -